Antimony resistance and gene expression inLeishmania: spotlight on molecular and proteomic aspects
Open Access
- 28 November 2023
- journal article
- review article
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 151 (1) , 1-14
Abstract
Leishmaniasis is a vector-borne parasitic disease caused byLeishmaniaparasites with a spectrum of clinical manifestations, ranging from skin lesions to severe visceral complications. Treatment of this infection has been extremely challenging with the concurrent emergence of drug resistance. The differential gene expression and the discrepancies in protein functions contribute to the appearance of 2 distinct phenotypes: resistant and sensitive, but the current diagnostic tools fail to differentiate between them. The identification of gene expression patterns and molecular mechanisms coupled with antimony (Sb) resistance can be leveraged to prompt diagnosis and select the most effective treatment methods. The present study attempts to use comparative expression of Sb resistance-associated genes in resistant and sensitiveLeishmania, to disclose their relative abundance in clinical orin vitroselected isolates to gain an understanding of the molecular mechanisms of Sb response/resistance. Data suggest that the analysis of resistance gene expression would verify the Sb resistance or susceptibility only to a certain extent; however, none of the individual expression patterns of the studied genes was diagnostic as a biomarker of Sb response ofLeishmania. The findings highlighted will be useful in bridging the knowledge gap and discovering innovative diagnostic tools and novel therapeutic targets.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (U01AI136033)
This publication has 156 references indexed in Scilit:
- Downregulation of Mitogen-Activated Protein Kinase 1 of Leishmania donovani Field Isolates Is Associated with Antimony ResistanceAntimicrobial Agents and Chemotherapy, 2012
- Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistanceGenome Research, 2011
- Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in LeishmaniaCell Death & Disease, 2011
- Sitamaquine Overcomes ABC-Mediated Resistance to Miltefosine and Antimony inLeishmaniaAntimicrobial Agents and Chemotherapy, 2011
- Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolatesMolecular and Biochemical Parasitology, 2010
- Proteome mapping of overexpressed membrane‐enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovaniBritish Journal of Clinical Pharmacology, 2010
- Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantumNucleic Acids Research, 2009
- Mammalian aquaporins: diverse physiological roles and potential clinical significanceExpert Reviews in Molecular Medicine, 2008
- Roles of Trypanothione S -Transferase and Tryparedoxin Peroxidase in Resistance to AntimonialsAntimicrobial Agents and Chemotherapy, 2008
- Increased levels of thiols protect antimony unresponsiveLeishmania donovanifield isolates against reactive oxygen species generated by trivalent antimonyParasitology, 2007